INTERNATIONAL PATENT: SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO., LTD., 上海洛启生物医药技术有限公司 FILES APPLICATION FOR "TL1A-BINDING MOLECULE AND USE THEREOF"

GENEVA, May 3 -- SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO., LTD. (Room 201, Building 10, Lane 500, Furonghua RoadPudong New Area, Shanghai 201321), 上海洛启生物医药技术有限公司 (中国上海市浦东新区芙蓉花路500弄10号201室) filed a patent application (PCT/CN2024/127453) for "TL1A-BINDING MOLECULE AND USE THEREOF" on Oct 25, 2024. With publication no. WO/2026/085874, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the...